Comprehensive Introduction to the Clinical Picture of Dementia
Etymology and Core Definition of Dementia
The term "dementia" originates from the Latin language, specifically combining the components "de" (meaning "without") and "mens" (meaning "spirit," "mind," or "intellect"). Effectively, it translates to being "without mind." Within a clinical framework, dementia is not defined as a single specific disease but rather as an umbrella term that describes a characteristic pattern of symptoms. For instance, Alzheimer's disease is recognized as one specific form or manifestation of dementia.
ICD-10 Clinical Definition
According to the ICD-10-Code classification, dementia is defined as a syndrome resulting from a mostly chronic or progressive disease of the brain. It is characterized by a disturbance of multiple higher cortical functions. These functions include memory, thinking, orientation, perception or comprehension, calculation, learning capacity, language, speech, judgment, and the ability to make decisions.
Several specific criteria must be met for a diagnosis under ICD-10 Guidelines: the consciousness of the individual must not be clouded; the symptoms must have persisted for a minimum duration of ; and the sensory organs and general perception must function within the person's usual parameters. These cognitive changes are frequently accompanied by alterations in emotional control, social behavior, and motivation.
Epidemiology and Frequency of Dementia
Statistical data highlights the significant impact of dementia across different regions. In Germany, as of the end of , approximately people were living with the condition. Of these, nearly were women and were men. The vast majority () were older than . The risk of developing dementia is directly correlated with life expectancy; as individuals age, the risk increases. Due to rising life expectancy and the aging of high-birth-rate generations, current estimates suggest that by the year , the number of affected individuals over in Germany will increase to approximately .
Global and European trends show similar trajectories. In , there were approximately people with dementia globally (data includes those aged and above). This is projected to rise to by . In Europe (EU & UK), as of , there were cases (data includes those aged and above), with a forecast of by .
Neuroanatomy and Pathophysiology
Dementia is fundamentally a disease of the brain involving the loss of nerve cells, often termed neurodegenerative disease. Key brain regions affected include the frontal lobe (Stirnhirn), the motor and sensory speech centers, the parietal lobe (Scheitellappen), the temporal lobe (Schläfenlappen), the occipital lobe (Okzipitallappen), the primary visual cortex (Sehrinde), the cerebellum (Kleinhirn), and the brainstem (Hirnstamm).
The disease leads to a physical degradation of brain tissue. Pathologically, damaged nerve cells are often characterized by abnormal protein deposits. In comparison to a normal brain, an Alzheimer's brain shows significant atrophy and structural loss.
Primary and Secondary Forms of Dementia
Dementia can be triggered by up to different causes, including Parkinson's disease, stroke, or Down syndrome. The specific symptoms presented depend on which areas of the brain are damaged. These causes are categorized into two main forms.
Primary Dementia involves organic damage directly to the brain via internal degradation processes. This category includes Alzheimer's disease ( of cases), vascular dementia ( of cases), and mixed forms of these two specific types ( of cases). Rarer forms include Lewy Body Disease (), Frontotemporal Dementia (FTD, ), and Chronic Traumatic Encephalopathy (CTE).
Secondary Dementia refers to dementia that occurs as a consequence of another underlying primary condition. Examples include metabolic diseases, poisoning from medications, vitamin deficiency states, depressions, brain tumors, and infections. Together, these and other causes comprise about of cases. Some of these causes are potentially treatable or reversible.
Pediatric Dementia (Kinderdemenz)
While dementia is typically associated with older adults, degenerative brain diseases can also manifest in children. Over different diseases are known to impair the cognitive abilities of children. Known collectively as "Childhood Dementia," these conditions are rare but severe. Children who develop normally in their first years gradually lose all learned skills and abilities as the disease progresses.
Cognitive Features and Specialized Terminology
Cognitive features are disorders of mental performance affecting how environmental signals are perceived and processed. Key terms include:
Amnesia: The total or partial inability to remember events, starting with short-term and eventually progressing to long-term memory loss (e.g., forgetting where keys were placed).
Disorientation: Changes in orientation regarding time, space/location, situation, and self (e.g., getting lost).
Agnosia: The inability to recognize objects, facts, persons, or faces despite intact sensory organs (e.g., not recognizing family members).
Aphasia: Disturbances in language including speaking, hearing, reading, and writing (e.g., searching for words).
Apraxie: The inability to consciously control purposeful and meaningful movement sequences (e.g., difficulty dressing in the correct order).
Abstraction Disorder: Changes in abstract thinking (e.g., difficulty making decisions).
Non-Cognitive and Psychological Symptoms
Non-cognitive features involve disturbances in feeling and behavior. They often include a depressive appearance, characterized by sadness, dejection, anger, diminished self-esteem, anxiety, and hopelessness. Behavioral changes can be challenging for caregivers, manifested as constant shouting, screaming, wandering, physical aggression (biting, scratching, hitting), or sexual disinhibition.
Other symptoms include hallucinations and delusions; circadian rhythm disturbances (disruption of day-night cycles); loss of social norms and inhibitions; and physical symptoms like sleep disorders, incontinence, and mobility restrictions. Personalities may also undergo a "reversal" where typical traits are replaced by their opposites.
Stages of Alzheimer's Disease Progression
The progression of dementia is highly individualized ("If you know one person with dementia, you know ONE person with dementia"). However, Alzheimer's typically follows three stages:
Light Dementia: Characterized by impaired short-term memory, word-finding difficulties, and orientation issues. The individual may maintain a "social facade" but experience depressive or aggressive moods and limited problem-solving skills.
Middle Dementia: Progressive restriction of thinking and memory. Communication becomes difficult as language is further impaired. The individual may live in past life phases, losing their current identity. Challenging behaviors like unrest and delusions increase.
Severe Dementia: Almost total loss of language (only vocalization), repetitive movement patterns, immobility, and no independent performance of daily activities. Loss of bowel and bladder control occurs. The end stage is marked by high vulnerability to all nursing risks, anxiety, and eventual death, often via infections.
Diagnostics and Prevention
Suspected cases must be medically clarified to rule out treatable causes like dehydration or depression. Diagnosis involves a doctor's consultation, physical and laboratory exams, and psychometric tests such as the Mini-Mental State Examination (MMSE) and the Clock Test. The MMSE takes approximately ; a score of less than suggests global cognitive impairment. Structural imaging includes Computed Tomography (CT) and Magnetic Resonance Imaging (MRT). Liquor diagnostics (cerebrospinal fluid) look for specific proteins, and genetic tests may be used if hereditary forms are suspected.
Prävention strategies include maintaining a balanced diet (such as a Mediterranean diet), reducing vascular risk factors, remaining mentally active, maintaining an active social life, and performing regular physical exercise.
Therapeutic Approaches and Medication
There is currently no cure for most forms of dementia. Treatment focuses on improving quality of life, preserving independence, and slowing symptom progression. A combination of pharmacological and non-pharmacological methods is usually most successful.
Pharmacological treatments target different domains:
Denken (Thinking): Antidementives like Cholinesterase inhibitors (e.g., Rivastigmine, Galantamine, Donepezil) improve signal transmission. Glutamate antagonists (e.g., Memantine) counteract excessive glutamate release.
Verhalten (Behavior): Neuroleptics (e.g., Risperidone, Haloperidole, Clozapine) treat delusions, hallucinations, and aggression.
Emotion: Antidepressants (e.g., Fluoxetine, Citalopram, Paroxetine) address depression and anxiety. Benzodiazepines may be used strictly for sleep disorders or severe anxiety.
Lecanemab (Leqembi) is a newer monoclonal antibody therapy approved in the EU since April for early-stage Alzheimer's. It works by breaking down beta-amyloid proteins. It is administered via infusion and requires regular MRT checks due to risks of brain edema or micro-bleeding.
Non-Pharmacological Therapies
Various concepts support people with dementia, including Reality Orientation, Biography work (remiscence), Cognitive training, and Basal Stimulation (physical touch). Other methods include Snoezelen, movement promotion, and Validation (specifically Integrative Validation). Person-centered care (as defined by Kitwood or Böhm), animal-assisted therapy (including robot animals), music/art therapy, and allied health services (Ergotherapy, Logopedics, Physiotherapy) are also integral. The choice of therapy varies depending on whether the dementia is mild, moderate, or severe.
Questions & Discussion
During the viewing of the film "Eines Tages…" (One Day), which provides insights into three families affected by dementia, students are tasked with documenting observations regarding:
How do people with dementia behave?
Which specific features (symptoms) of dementia can be observed?